AK

Anil Kumar

Active Director Director DIN 06728221
DIN 06728221 First appointment Dec 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2013
Shareholding value •••• Premium profile

About Anil Kumar

Data last updated:

Anil Kumar is a Director at Denice Pharmaceuticals Private Limited (since 2013). The company operates in Trading. Denice Pharmaceuticals Private Limited reported revenue of ₹5.9 Lakh (FY 2022).

DIN 06728221
Primary Designation Director
Industry Trading
First Appointment 06 Dec 2013
Oldest Company Age 12 yrs
Largest company Denice Pharmaceuticals Private Limited · ₹5.9 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Dec 20132013₹5.9 Lakh (FY 2022)Active

Board colleagues of Anil Kumar

NameDINCompanyDesignation
Ranjana Singh08298389Denice Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Denice Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anil Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Kumar

Anil Kumar currently holds 1 directorship: Denice Pharmaceuticals Private Limited (Director, since 06 Dec 2013, revenue ₹5.9 Lakh (FY 2022)).

Anil Kumar was first appointed on 06 Dec 2013 as Director at Denice Pharmaceuticals Private Limited.

The current boards of Anil Kumar's companies include Ranjana Singh (Denice Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available